Rowland Thomas Andrew sold ANIP
August 12, 2025 · Form 4 insider transaction
Rowland Thomas Andrew sold 4,975 shares of ANI Pharmaceuticals, Inc. at $85.71 per share, a transaction worth $426.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
4,975
Price
$85.71
Total value
$426.4K
InsiderRowland Thomas Andrew
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 12, 2025
Filing dateAugust 14, 2025
Shares owned after40,794
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were sold in multiple trades at prices ranging from $85.52 to $86.22. The price reported above reflects the weighted average sales price.; Includes 304 shares of ANI Pharmaceuticals, Inc. Common Stock that were acquired under the ANI Pharmaceuticals, Inc. Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(d) and Rule 16b-3(c).